Patents Assigned to CHIBI, INC.
  • LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE
    Publication number: 20240285520
    Abstract: The present embodiments provide compositions, methods, and kits for the treatment or prevention of ocular conditions or maladies via non-invasive liquid depots. In at least one embodiment, the liquid depot is capable of sustained-release delivery of at least one pharmaceutical agent to the eye for days or weeks.
    Type: Application
    Filed: April 30, 2024
    Publication date: August 29, 2024
    Applicant: Chibi, Inc.
    Inventors: Vernon G. Wong, Glenn T. Huang
  • Eye drop formulation and method for sustained delivery of medicament to the retina
    Patent number: 11497710
    Abstract: The present embodiments provide compositions, methods and kits for the treatment of ocular conditions or maladies affecting the back of the eye, e.g., the retina.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: November 15, 2022
    Assignee: CHIBI, INC.
    Inventors: Vernon G. Wong, Glenn T. Huang
  • LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE
    Publication number: 20220168219
    Abstract: The present embodiments provide compositions, methods, and kits for the treatment or prevention of ocular conditions or maladies via non-invasive liquid depots. In at least one embodiment, the liquid depot is capable of sustained-release delivery of at least one pharmaceutical agent to the eye for days or weeks.
    Type: Application
    Filed: December 9, 2021
    Publication date: June 2, 2022
    Applicant: CHIBI, INC.
    Inventors: VERNON G. WONG, GLENN T. HUANG
  • Liquid depot for non-invasive sustained delivery of agents to the eye
    Patent number: 11234926
    Abstract: The present embodiments provide compositions, methods, and kits for the treatment or prevention of ocular conditions or maladies via non-invasive liquid depots. In at least one embodiment, the liquid depot is capable of sustained-release delivery of at least one pharmaceutical agent to the eye for days or weeks.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: February 1, 2022
    Assignee: CHIBI, INC.
    Inventors: Vernon G. Wong, Glenn T. Huang